TrialCritical care (London, England)2022

A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.

Gebhard Wagener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.